Rankings
▼
Calendar
BDX Q2 2024 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena
BDX
Becton, Dickinson and Company
$60B
Q2 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$5.0B
+4.6% YoY
Gross Profit
$2.3B
45.7% margin
Operating Income
$734M
14.5% margin
Net Income
$537M
10.6% margin
EPS (Diluted)
$1.85
QoQ Revenue Growth
+7.2%
Cash Flow
Operating Cash Flow
$515M
Free Cash Flow
$381M
Stock-Based Comp.
$60M
Balance Sheet
Total Assets
$54.2B
Total Liabilities
$28.5B
Stockholders' Equity
$25.6B
Cash & Equivalents
$2.3B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.0B
$4.8B
+4.6%
Gross Profit
$2.3B
$2.2B
+3.1%
Operating Income
$734M
$628M
+16.9%
Net Income
$537M
$460M
+16.7%
Revenue Segments
Medical
$2.4B
49%
Life Sciences
$1.3B
26%
Interventional
$1.3B
26%
Geographic Segments
UNITED STATES
$2.9B
58%
Non-US
$2.1B
42%
← FY 2024
All Quarters
Q3 2024 →